TCL Archive New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis June 25, 1976
TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research December 15, 1995
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention November 16, 1979
